SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-320678
Filing Date
2020-12-18
Accepted
2020-12-18 06:30:01
Documents
18
Period of Report
2020-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d10033d8k.htm   iXBRL 8-K 30761
2 EX-1.1 d10033dex11.htm EX-1.1 152545
3 EX-5.1 d10033dex51.htm EX-5.1 10213
4 EX-99.1 d10033dex991.htm EX-99.1 9107
8 GRAPHIC g10033a1.jpg GRAPHIC 2918
9 GRAPHIC g10033a2.jpg GRAPHIC 16960
10 GRAPHIC g10033a3.jpg GRAPHIC 13014
  Complete submission text file 0001193125-20-320678.txt   425716

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arvn-20201215.xsd EX-101.SCH 3068
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20201215_lab.xml EX-101.LAB 18889
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20201215_pre.xml EX-101.PRE 11859
11 EXTRACTED XBRL INSTANCE DOCUMENT d10033d8k_htm.xml XML 3470
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 201397962
SIC: 2834 Pharmaceutical Preparations